XSpray Pharma (Sweden) Today
| XSPRAY Stock | SEK 39.70 1.00 2.46% |
Performance5 of 100
| Odds Of DistressOver 63
|
XSpray Pharma is trading at 39.70 as of the 19th of April 2024, a -2.46 percent decrease since the beginning of the trading day. The stock's open price was 40.7. XSpray Pharma has more than 63 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for XSpray Pharma AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Xspray Pharma AB engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. Xspray Pharma AB was founded in 2003 and is based in Solna, Sweden. Xspray Pharma is traded on Stockholm Stock Exchange in Sweden. The company has 22.68 M outstanding shares. More on XSpray Pharma AB
Moving together with XSpray Stock
| 0.67 | VITR | Vitrolife AB | PairCorr |
Moving against XSpray Stock
| 0.71 | GENO | Genovis AB | PairCorr |
| 0.61 | HEIM-PREF | Heimstaden AB Pfd | PairCorr |
| 0.58 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.56 | ARION-SDB | Arion banki hf | PairCorr |
| 0.53 | CAMX | Camurus AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
XSpray Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. XSpray Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding XSpray Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
XSpray Pharma AB (XSPRAY) is traded on Stockholm Exchange in Sweden and employs 26 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate XSpray Pharma's market, we take the total number of its shares issued and multiply it by XSpray Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. XSpray Pharma AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 22.68 M outstanding shares.
XSpray Pharma AB has accumulated about 192.85 M in cash with (51.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.79.
Check XSpray Pharma Probability Of Bankruptcy
Ownership AllocationXSpray Pharma AB retains a total of 22.68 Million outstanding shares. XSpray Pharma AB owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check XSpray Ownership Details
XSpray Stock Price Odds Analysis
What are XSpray Pharma's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of XSpray Pharma jumping above the current price in 90 days from now is about 52.63%. The XSpray Pharma AB probability density function shows the probability of XSpray Pharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon XSpray Pharma has a beta of 0.3015. This entails as returns on the market go up, XSpray Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding XSpray Pharma AB will be expected to be much smaller as well. Additionally, xSpray Pharma AB has an alpha of 0.207, implying that it can generate a 0.21 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of XSpray Pharma to move above the current price in 90 days from now is about 52.63 (This XSpray Pharma AB probability density function shows the probability of XSpray Stock to fall within a particular range of prices over 90 days) .
XSpray Pharma AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. XSpray Pharma market risk premium is the additional return an investor will receive from holding XSpray Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in XSpray Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although XSpray Pharma's alpha and beta are two of the key measurements used to evaluate XSpray Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.04 | |||
| Semi Deviation | 2.24 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.15 |
XSpray Stock Against Markets
Picking the right benchmark for XSpray Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in XSpray Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for XSpray Pharma is critical whether you are bullish or bearish towards XSpray Pharma AB at a given time. Please also check how XSpray Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in XSpray Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
XSpray Pharma Corporate Management
Elected by the shareholders, the XSpray Pharma's board of directors comprises two types of representatives: XSpray Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of XSpray. The board's role is to monitor XSpray Pharma's management team and ensure that shareholders' interests are well served. XSpray Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, XSpray Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kerstin Hasselgren | Chief Officer | Profile | |
| Per Andersson | Chief Officer | Profile | |
| Charlotta Liljebris | VP RD | Profile | |
| Andreas Konar | Sr Devel | Profile | |
| Thomas Walz | Chief Officer | Profile | |
| AnnaKarin Ekberg | VP Sales | Profile | |
| Christina Hagerstrand | VP Relations | Profile |
How to buy XSpray Stock?
Before investing in XSpray Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in XSpray Pharma. To buy XSpray Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of XSpray Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase XSpray Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located XSpray Pharma AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased XSpray Pharma AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as XSpray Pharma AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in XSpray Pharma AB?
The danger of trading XSpray Pharma AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of XSpray Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than XSpray Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile XSpray Pharma AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XSpray Pharma AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the XSpray Pharma AB information on this page should be used as a complementary analysis to other XSpray Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for XSpray Stock analysis
When running XSpray Pharma's price analysis, check to measure XSpray Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XSpray Pharma is operating at the current time. Most of XSpray Pharma's value examination focuses on studying past and present price action to predict the probability of XSpray Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XSpray Pharma's price. Additionally, you may evaluate how the addition of XSpray Pharma to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |